Last reviewed · How we verify

Pyruvic acid — Competitive Intelligence Brief

Pyruvic acid (Pyruvic acid) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Metabolic supplement / Organic acid. Area: Metabolic disorders / General wellness.

marketed Metabolic supplement / Organic acid Metabolic disorders / General wellness Small molecule Live · refreshed every 30 min

Target snapshot

Pyruvic acid (Pyruvic acid) — Isfahan University of Medical Sciences. Pyruvic acid is an endogenous metabolite that serves as a central hub in cellular energy metabolism, facilitating the conversion of carbohydrates, amino acids, and fats into acetyl-CoA for ATP production.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Pyruvic acid TARGET Pyruvic acid Isfahan University of Medical Sciences marketed Metabolic supplement / Organic acid

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Metabolic supplement / Organic acid class)

  1. Isfahan University of Medical Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Pyruvic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/pyruvic-acid. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: